Three Cases of Monoclonal Gammopathy of Renal Significance After Kidney Transplantation. De Novo C3 Glomerulopathy
Overview
Authors
Affiliations
Monoclonal gammopathy of renal significance includes all renal disorders caused by a monoclonal immunoglobulin secreted by a non-malignant B-cell clone. Patients with MGRS do not, by definition, meet criteria for multiple myeloma, with haematological disorders generally considered to be monoclonal gammopathy of undetermined significance. Nevertheless, the renal involvement can be serious and require specific treatment. Monoclonal gammopathy of renal significance is associated with a wide spectrum of disorders, including the recently discovered C3 glomerulopathy. Development of C3 glomerulopathy in the context of monoclonal gammopathy of renal significance after kidney transplantation is uncommon and very few cases have been published to date. We report on three cases of C3 glomerulopathy in the context of de novo monoclonal gammopathy after kidney transplantation.
Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options.
Bartoli G, Dello Strologo A, Grandaliano G, Pesce F Int J Mol Sci. 2024; 25(12).
PMID: 38928213 PMC: 11204074. DOI: 10.3390/ijms25126508.
Ruiz-Fuentes M, Caba-Molina M, Polo-Moyano A, Palomares-Bayo M, Galindo-Sacristan P, De Gracia-Guindo C Am J Case Rep. 2023; 24:e939726.
PMID: 37329130 PMC: 10286632. DOI: 10.12659/AJCR.939726.
Treatment of C3 Glomerulopathy in Adult Kidney Transplant Recipients: A Systematic Review.
Gonzalez Suarez M, Thongprayoon C, Hansrivijit P, Kovvuru K, Kanduri S, Aeddula N Med Sci (Basel). 2020; 8(4).
PMID: 33096866 PMC: 7712822. DOI: 10.3390/medsci8040044.